Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Nature Medicine|July 4, 2001
A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translationE Griffin, A Re, N Hamel, et al.Journal of Medical Genetics|October 4, 2005
The HNPCC associated MSH2*1906G-->C founder mutation probably originated between 1440 CE and 1715 CE in the Ashkenazi Jewish populationS Sun, C M T Greenwood, I Thiffault, et al.Genetics|May 1, 1996
Nuclear genes associated with a single Brassica CMS restorer locus influence transcripts of three different mitochondrial gene regionsM Singh, N Hamel, R Menassa, et al.Clinical Genetics|January 6, 2011
A founder BRCA2 mutation in non-Afrikaner breast cancer patients of the Western Cape of South AfricaN C van der Merwe, N Hamel, S-R Schneider, et al.Journal of Allied Health|November 30, 2023
Prematriculation Predictors of Academic Difficulties During the First Year of a Doctor of Physical Therapy ProgramJeffrey B Taylor, Dora J Gosselin, Paul W Kline, et al.British Journal of Cancer|May 19, 2000
Polymorphisms in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinomaG Liu, P Ghadirian, D Vesprini, et al.British Journal of Cancer|August 11, 2011
Genetic architecture of prostate cancer in the Ashkenazi Jewish populationJ Vijai, T Kirchhoff, D Gallagher, et al.Familial Cancer|October 24, 2003
Double primary cancers of the breast and thyroid in women: molecular analysis and genetic implicationsT Pal, N Hamel, D Vesprini, et al.Clinical Genetics|July 17, 2001
Prevalence of founder BRCA1 and BRCA2 mutations in unselected French Canadian women with breast cancerP O Chappuis, N Hamel, A J Paradis, et al.British Journal of Cancer|September 11, 2003
Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancerJ R Goffin, O Straume, P O Chappuis, et al.Pageof 3